Study of the Esophageal String Test (EST) for the Diagnosis of Helicobacter Pylori
- Conditions
- Helicobacter Pylori
- First Posted Date
- 2025-03-12
- Last Posted Date
- 2025-05-21
- Target Recruit Count
- 25
- Registration Number
- NCT06871579
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
- Conditions
- Influenza PreventionSeasonal Influenza
- Interventions
- Other: ALFQ
- First Posted Date
- 2025-03-07
- Last Posted Date
- 2025-05-21
- Target Recruit Count
- 45
- Registration Number
- NCT06863142
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy
- Conditions
- X-linked Severe Combined ImmunodeficiencyX-SCIDXSCID
- Interventions
- Genetic: PlerixaforBiological: Base-edited hematopoietic stem and progenitor cells
- First Posted Date
- 2025-02-28
- Last Posted Date
- 2025-05-18
- Target Recruit Count
- 18
- Registration Number
- NCT06851767
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Safety and Challenge Study of BCG TICE(R) Vaccination to Test Tuberculosis Immunity in Heathy Humans
- Conditions
- Tuberculosis
- Interventions
- Biological: BCG TICE strainOther: Sodium Chloride, 0.9%Other: Sterile Water for Injection
- First Posted Date
- 2025-02-25
- Last Posted Date
- 2025-05-20
- Target Recruit Count
- 64
- Registration Number
- NCT06845358
EVR and EPO for Liver Transplant Tolerance
- First Posted Date
- 2025-02-18
- Last Posted Date
- 2025-03-14
- Target Recruit Count
- 20
- Registration Number
- NCT06832189
- Locations
- 🇺🇸
University of California San Francisco School of Medicine, San Francisco, California, United States
🇺🇸Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
🇺🇸University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States
Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People Living With HIV Receiving Antiretroviral Therapy
- First Posted Date
- 2025-02-11
- Last Posted Date
- 2025-05-21
- Target Recruit Count
- 50
- Registration Number
- NCT06819176
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV
- Conditions
- HIV
- Interventions
- Biological: VRC07-523LS 400mgBiological: VRC07-523LS 3200mgBiological: PGT121.414.LS 400mgBiological: PGT121.414.LS 1600mgBiological: PGDM1400LS 400mgBiological: PGDM1400LS 1600mg
- First Posted Date
- 2025-02-06
- Last Posted Date
- 2025-03-25
- Target Recruit Count
- 200
- Registration Number
- NCT06812494
- Locations
- 🇺🇸
Bridge HIV, San Francisco Department of Public Health, San Francisco, California, United States
🇺🇸The Hope Clinic of the Emory Vaccine Research Center; Emory University, Decatur, Georgia, United States
🇺🇸Fenway Health, Boston, Massachusetts, United States
Evaluation of the Protective Efficacy of TV003 or Previous Zika Infection Against Infection With ZIKV-SJRP Challenge Compared to DENV and ZIKV-naïve Controls Against Infection With ZIKV-SJRP Challenge
- Conditions
- Zika Virus
- Interventions
- Biological: TetraVax-DV-TV003 (TV003)Biological: PlasmalyteBiological: Challenge virus ZIKV-SJRP/2016-184
- First Posted Date
- 2025-02-03
- Last Posted Date
- 2025-02-03
- Target Recruit Count
- 26
- Registration Number
- NCT06805487
- Locations
- 🇺🇸
Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland, United States
🇺🇸Center for Immunization Research, Baltimore, Maryland, United States
Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine in Healthy Adults
- Conditions
- West Nile Viral Infection
- Interventions
- Biological: HydroVax-001B WNVOther: PlaceboOther: Sodium Chloride, 0.9%
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2025-05-16
- Target Recruit Count
- 30
- Registration Number
- NCT06745921
- Locations
- 🇺🇸
Saint Louis University Center for Vaccine Development, Saint Louis, Missouri, United States
First-in-Human PfSPZ-LARC2 Vaccination/CHMI
- Conditions
- Malaria
- Interventions
- First Posted Date
- 2024-12-16
- Last Posted Date
- 2025-04-25
- Target Recruit Count
- 40
- Registration Number
- NCT06735209
- Locations
- 🇺🇸
The University of Washington - Virology Research Clinic, Seattle, Washington, United States